Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ITRACONAZOLE
(1992)
Small molecule
Cytochrome P450 51 inhibitor
INJECTION; ORAL
Approved
Aspergillosis; Blastomycosis; Candidiasis; Lung Diseases; Mycoses; Onychomycosis
ITRACONAZOLE
×
Maximum Phase:
4
First Approval:
1992
UNII:
304NUG5GF4
Molecule Type:
Small molecule
Molecular Formula:
C35H38Cl2N8O4
Molecular Weight:
705.65
AlogP:
5.58
PSA:
104.7
HBD:
0.0
HBA:
#RotB:
11.0
Source:
RIFABUTIN
(1992)
Small molecule
Bacterial DNA-directed RNA polymerase inhibitor
ORAL
Approved
HIV Infections; Mycobacterium avium-intracellulare Infection; Tuberculosis
RIFABUTIN
×
Maximum Phase:
4
First Approval:
1992
UNII:
1W306TDA6S
Molecule Type:
Small molecule
Molecular Formula:
C46H62N4O11
Molecular Weight:
847.02
AlogP:
4.62
PSA:
205.55
HBD:
5.0
HBA:
#RotB:
4.0
Source:
TENIPOSIDE
(1992)
Small molecule
DNA topoisomerase II inhibitor
INJECTION
Approved
Neoplasms
TENIPOSIDE
×
Maximum Phase:
4
First Approval:
1992
UNII:
957E6438QA
Molecule Type:
Small molecule
Molecular Formula:
C32H32O13S
Molecular Weight:
656.66
AlogP:
2.75
PSA:
160.83
HBD:
3.0
HBA:
#RotB:
6.0
Source:
HALOFANTRINE
(1992)
Small molecule
Unknown
Unknown
Approved
Malaria
HALOFANTRINE
×
Maximum Phase:
4
First Approval:
1992
UNII:
Q2OS4303HZ
Molecule Type:
Small molecule
Molecular Formula:
C26H30Cl2F3NO
Molecular Weight:
500.43
AlogP:
8.64
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
10.0
Source:
TEMAFLOXACIN
(1992)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
TEMAFLOXACIN
×
Maximum Phase:
4
First Approval:
1992
UNII:
1WZ12GTT67
Molecule Type:
Small molecule
Molecular Formula:
C21H18F3N3O3
Molecular Weight:
417.39
AlogP:
2.9
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MASOPROCOL
(1992)
Small molecule
Unknown
TOPICAL
Approved
Neoplasms
MASOPROCOL
×
Maximum Phase:
4
First Approval:
1992
UNII:
7BO8G1BYQU
Molecule Type:
Small molecule
Molecular Formula:
C18H22O4
Molecular Weight:
302.37
AlogP:
3.57
PSA:
80.92
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PAROXETINE
(1992)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
PAROXETINE
×
Maximum Phase:
4
First Approval:
1992
UNII:
41VRH5220H
Molecule Type:
Small molecule
Molecular Formula:
C19H20FNO3
Molecular Weight:
329.37
AlogP:
3.33
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SOTALOL
(1992)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
SOTALOL
×
Maximum Phase:
4
First Approval:
1992
UNII:
A6D97U294I
Molecule Type:
Small molecule
Molecular Formula:
C12H20N2O3S
Molecular Weight:
272.37
AlogP:
1.09
PSA:
78.43
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TERBINAFINE HYDROCHLORIDE
(1992)
Small molecule
Squalene monooxygenase inhibitor
ORAL; TOPICAL
Approved
Unknown
TERBINAFINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1992
UNII:
012C11ZU6G
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClN
Molecular Weight:
327.9
AlogP:
4.88
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DESOGESTREL
(1992)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
DESOGESTREL
×
Maximum Phase:
4
First Approval:
1992
UNII:
81K9V7M3A3
Molecule Type:
Small molecule
Molecular Formula:
C22H30O
Molecular Weight:
310.48
AlogP:
4.87
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LEVOMETHADYL ACETATE HYDROCHLORIDE
(1993)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Unknown
LEVOMETHADYL ACETATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
B54CW5KG52
Molecule Type:
Small molecule
Molecular Formula:
C23H32ClNO2
Molecular Weight:
389.97
AlogP:
4.65
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
FENOFIBRATE
(1993)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hypothyroidism
FENOFIBRATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
U202363UOS
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClO4
Molecular Weight:
360.84
AlogP:
4.68
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
6.0
Source:
PERINDOPRIL ERBUMINE
(1993)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Coronary Artery Disease; Hypertension
PERINDOPRIL ERBUMINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
1964X464OJ
Molecule Type:
Small molecule
Molecular Formula:
C23H43N3O5
Molecular Weight:
441.61
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
RISPERIDONE
(1993)
Small molecule
Dopamine D2 receptor antagonist
INTRAMUSCULAR; ORAL; SUBCUTANEOUS
Approved
Aggression; Autistic Disorder; Bipolar Disorder; Psychotic Disorders; Schizophrenia
RISPERIDONE
×
Maximum Phase:
4
First Approval:
1993
UNII:
L6UH7ZF8HC
Molecule Type:
Small molecule
Molecular Formula:
C23H27FN4O2
Molecular Weight:
410.49
AlogP:
3.59
PSA:
64.16
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LODOXAMIDE
(1993)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations
LODOXAMIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
SPU695OD73
Molecule Type:
Small molecule
Molecular Formula:
C11H6ClN3O6
Molecular Weight:
311.64
AlogP:
0.26
PSA:
156.59
HBD:
4.0
HBA:
#RotB:
2.0
Source:
PERINDOPRIL
(1993)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PERINDOPRIL
×
Maximum Phase:
4
First Approval:
1993
UNII:
Y5GMK36KGY
Molecule Type:
Small molecule
Molecular Formula:
C19H32N2O5
Molecular Weight:
368.47
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TAZOBACTAM
(1993)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
TAZOBACTAM
×
Maximum Phase:
4
First Approval:
1993
UNII:
SE10G96M8W
Molecule Type:
Small molecule
Molecular Formula:
C10H12N4O5S
Molecular Weight:
300.3
AlogP:
-1.52
PSA:
122.46
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GRANISETRON HYDROCHLORIDE
(1993)
Small molecule
Serotonin 3a (5-HT3a) receptor antagonist
INJECTION; ORAL
Approved
Nausea; Postoperative Nausea and Vomiting
GRANISETRON HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
318F6L70J8
Molecule Type:
Small molecule
Molecular Formula:
C18H25ClN4O
Molecular Weight:
348.88
AlogP:
2.32
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
2.0
Source:
STRONTIUM CHLORIDE SR 89
(1993)
Small molecule
Unknown
Unknown
Approved
Neoplasm Metastasis
STRONTIUM CHLORIDE SR 89
×
Maximum Phase:
4
First Approval:
1993
UNII:
5R78837D4A
Molecule Type:
Small molecule
Molecular Formula:
Cl2Sr
Molecular Weight:
159.81
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PERFLUBRON
(1993)
Small molecule
Unknown
ORAL
Approved
Unknown
PERFLUBRON
×
Maximum Phase:
4
First Approval:
1993
UNII:
Q1D0Q7R4D9
Molecule Type:
Small molecule
Molecular Formula:
C8BrF17
Molecular Weight:
498.96
AlogP:
6.35
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
6.0
Source:
GADODIAMIDE
(1993)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
GADODIAMIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
84F6U3J2R6
Molecule Type:
Small molecule
Molecular Formula:
C16H26GdN5O8
Molecular Weight:
573.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRIMETREXATE
(1993)
Small molecule
Unknown
Unknown
Approved
Unknown
TRIMETREXATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
UPN4ITI8T4
Molecule Type:
Small molecule
Molecular Formula:
C19H23N5O3
Molecular Weight:
369.43
AlogP:
2.74
PSA:
117.54
HBD:
3.0
HBA:
#RotB:
6.0
Source:
RIMANTADINE
(1993)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
RIMANTADINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
0T2EF4JQTU
Molecule Type:
Small molecule
Molecular Formula:
C12H21N
Molecular Weight:
179.31
AlogP:
2.55
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
1.0
Source:
STRONTIUM CHLORIDE
(1993)
Small molecule
Unknown
Unknown
Approved
Unknown
STRONTIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
EKE8PS9J6Z
Molecule Type:
Small molecule
Molecular Formula:
Cl2Sr
Molecular Weight:
158.53
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CALCIPOTRIENE
(1993)
Small molecule
Vitamin D receptor agonist
TOPICAL
Approved
Psoriasis
CALCIPOTRIENE
×
Maximum Phase:
4
First Approval:
1993
UNII:
143NQ3779B
Molecule Type:
Small molecule
Molecular Formula:
C27H40O3
Molecular Weight:
412.61
AlogP:
5.09
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LORATADINE
(1993)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Hypersensitivity; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria
LORATADINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
7AJO3BO7QN
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClN2O2
Molecular Weight:
382.89
AlogP:
4.89
PSA:
42.43
HBD:
0.0
HBA:
#RotB:
1.0
Source:
TORSEMIDE
(1993)
Small molecule
Sodium-(potassium)-chloride cotransporter 2 inhibitor
INJECTION; ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Stroke
TORSEMIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
W31X2H97FB
Molecule Type:
Small molecule
Molecular Formula:
C16H20N4O3S
Molecular Weight:
348.43
AlogP:
2.53
PSA:
100.19
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TRIMETREXATE GLUCURONATE
(1993)
Small molecule
Dihydrofolate reductase inhibitor
INJECTION
Approved
Unknown
TRIMETREXATE GLUCURONATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
L137U4A79K
Molecule Type:
Small molecule
Molecular Formula:
C25H33N5O10
Molecular Weight:
563.56
AlogP:
2.74
PSA:
117.54
HBD:
3.0
HBA:
#RotB:
6.0
Source:
LEVOCABASTINE HYDROCHLORIDE
(1993)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Unknown
LEVOCABASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
124XMA6YEI
Molecule Type:
Small molecule
Molecular Formula:
C26H30ClFN2O2
Molecular Weight:
456.99
AlogP:
4.89
PSA:
64.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOCABASTINE
(1993)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Nasal Obstruction
LEVOCABASTINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
H68BP06S81
Molecule Type:
Small molecule
Molecular Formula:
C26H29FN2O2
Molecular Weight:
420.53
AlogP:
4.89
PSA:
64.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOMETHADYL ACETATE
(1993)
Small molecule
Unknown
Unknown
Approved
Substance-Related Disorders
LEVOMETHADYL ACETATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
R3B637Y991
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO2
Molecular Weight:
353.51
AlogP:
4.65
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
TAZOBACTAM SODIUM
(1993)
Small molecule
Bacterial beta-lactamase TEM inhibitor
Unknown
Approved
Appendicitis; Cellulitis; Diabetic Foot; Endometritis; Healthcare-Associated Pneumonia; Intraabdominal Infections; Pelvic Inflammatory Disease; Peritonitis; Pneumonia; Urinary Tract Infections
TAZOBACTAM SODIUM
×
Maximum Phase:
4
First Approval:
1993
UNII:
UXA545ABTT
Molecule Type:
Small molecule
Molecular Formula:
C10H11N4NaO5S
Molecular Weight:
322.28
AlogP:
-1.52
PSA:
122.46
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PANTOTHENIC ACID
(1993)
Small molecule
Unknown
Unknown
Approved
Kidney Failure, Chronic
PANTOTHENIC ACID
×
Maximum Phase:
4
First Approval:
1993
UNII:
19F5HK2737
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO5
Molecular Weight:
219.24
AlogP:
-1.04
PSA:
106.86
HBD:
4.0
HBA:
#RotB:
6.0
Source:
RIMANTADINE HYDROCHLORIDE
(1993)
Small molecule
Influenza virus A matrix protein M2 inhibitor
ORAL
Approved
Infections; Influenza, Human
RIMANTADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
JEI07OOS8Y
Molecule Type:
Small molecule
Molecular Formula:
C12H22ClN
Molecular Weight:
215.77
AlogP:
2.55
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TACRINE
(1993)
Small molecule
Unknown
Unknown
Approved
Dementia
TACRINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
4VX7YNB537
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2
Molecular Weight:
198.27
AlogP:
2.7
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GABAPENTIN
(1993)
Small molecule
Voltage-gated calcium channel modulator
ORAL
Approved
Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome; Seizures
GABAPENTIN
×
Maximum Phase:
4
First Approval:
1993
UNII:
6CW7F3G59X
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO2
Molecular Weight:
171.24
AlogP:
1.37
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
40
41
42
43
44
45
46
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA